Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Celltrion
Manufacturing
Celltrion earmarks $478M to bolster US manufacturing capacity
Two months after Celltrion bought a U.S. plant from Eli Lilly for $330M, the company said it will spend another $478M to upgrade the API facility.
Kevin Dunleavy
Nov 19, 2025 11:31am
Lilly-XtalPi, Celltrion, Illumina in China—Fierce Pharma Asia
Nov 7, 2025 9:41am
Regeneron, Celltrion shake hands on Eylea biosimilar settlement
Oct 22, 2025 8:15am
Celltrion buy, Rexulti CRL, Glenmark-Hengrui—Fierce Pharma Asia
Sep 26, 2025 10:00am
Korea's Celltrion throws down $330M for Lilly plant in N.J.
Sep 23, 2025 9:24am
BMS JV sale, biotech debuts, possible deals—Fierce Pharma Asia
Sep 19, 2025 8:36am
